Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 10 min ago

Boston Scientific Announces U.S. FDA Approval of Navigation-Enabled Ablation Catheters

Wed, 05/04/2016 - 04:00
New catheters and software enhancement expand capabilities of high-definition Rhythmia™ Mapping System MARLBOROUGH, Mass., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) has received U.S. Food and Drug Administration (...
Devices, Cardiology, FDA, Product Launch
Boston Scientific, Rhythmia Mapping System, IntellaNav

Spinal Simplicity Lands Investor In Nueterra Capital, Advances Opportunity For FDA-Cleared Minuteman Fusion Device

Tue, 05/03/2016 - 23:02
Manufacturer of surgical solutions expands innovative spinal surgery in U.S. market LEAWOOD, Kan., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Spinal Simplicity, a medical device company based in Overland Park, Kan., that develops innovati...
Devices, Orthopaedic, Neurosurgery, Venture Capital
Spinal Simplicity, Minuteman, spinal fusion

First Ray Receives FDA 510(k) Clearance for Stealth Staple(TM)

Tue, 05/03/2016 - 20:51
LOGAN, Utah, May 3, 2016 -- (Healthcare Sales & Marketing Network) -- First Ray, a start-up medical device company focused on advanced surgical devices for improving outcomes for orthopaedic extremity procedures, announces that it has received FDA 510(k) ...
Devices, Orthopaedic, Surgery, FDA
First Ray, Stealth Staple, bone fixation

Intec Pharma Appoints VP of Clinical and Regulatory Affairs

Tue, 05/03/2016 - 20:48
JERUSALEM, May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Intec Pharma Ltd. (NTEC) (INTP.TA), a clinical-stage biopharmaceutical company, today announced the appointment of Pnina Strauss-Levy as Vice President, Clinical and Regulatory Affairs. ...
Biopharmaceuticals, Drug Delivery, Personnel
Intec Pharma, Accordion Pill

Eiger Bio Strengthens Senior Management Team with Announcement of Debra Odink, PhD as Senior Vice President of Technical Operations

Tue, 05/03/2016 - 20:46
PALO ALTO, Calif., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Eiger BioPharmaceuticals, Inc. (EIGR), a biopharmaceutical company focused on the development and commercialization of targeted therapies for Orphan diseases, announced today the ...
Biopharmaceuticals, Personnel
Eiger BioPharmaceuticals, Hepatitis Delta Virus

Patara Pharma Appoints Biotechnology Industry Leader John Schmid to Board of Directors

Tue, 05/03/2016 - 20:44
Seasoned Corporate Finance Executive Adds Strategic Fiscal Expertise SAN DIEGO, May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Patara Pharma, a clinical-stage biopharmaceutical company developing new therapeutics that significantly improve th...
Biopharmaceuticals, Personnel
Patara Pharma, idiopathic pulmonary fibrosis

Bioniz Therapeutics Appoints Fredrik Wiklund as Chief Operating Officer

Tue, 05/03/2016 - 20:42
IRVINE, Calif., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Bioniz Therapeutics, Inc., a biopharmaceutical company leading the discovery and development of first-in-class peptide therapeutics that selectively inhibit multiple cytokines to add...
Biopharmaceuticals, Oncology, Personnel
Bioniz Therapeutics

XBiotech Appoints Amgen Veteran Scott Whitehurst as Chief Financial Officer

Tue, 05/03/2016 - 20:40
AUSTIN, Texas, May 03, 2016 -- (Healthcare Sales & Marketing Network) -- XBiotech Inc. (XBIT), developer of True Human™ therapeutic antibodies, announced the appointment of Scott Whitehurst as Chief Financial Officer, effective today. He will oversee the C...
Biopharmaceuticals, Oncology, Personnel
XBiotech, True Human, Xilonix, colorectal cancer

NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales

Tue, 05/03/2016 - 13:56
BEDFORD, Mass.--(Healthcare Sales & Marketing Network)--NinePoint Medical, Inc., a transformative medical device company that is pioneering the clinical use of a real-time imaging platform based upon a proprietary optical coherence tomography (OCT) technol...
Devices, Personnel
NinePoint Medical, optical coherence tomography, NvisionVLE

Joseph C. Papa Assumes Role Of Chairman And Chief Executive Officer Of Valeant Pharmaceuticals

Tue, 05/03/2016 - 13:49
LAVAL, Quebec, May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that Joseph C. Papa has assumed the role of Chairman and Chief Executive Officer. As previously an...
Biopharmaceuticals, Dermatology, Personnel
Valeant Pharmaceuticals

SI-BONE, Inc. Surpasses 20,000 Surgeries With Triangular iFuse Implant System - Expands International Presence to 25 Countries

Tue, 05/03/2016 - 13:44
40 Peer-Reviewed Publications are Driving Adoption Among Patients, Surgeons and Health Plans SAN JOSE, Calif., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- SI-BONE, Inc., a medical device company that pioneered the use of the iFuse Implant ...
Devices, Neurosurgery, Orthopaedic
SI-BONE, iFuse Implant, SI joint, spine surgery

EnteroMedics Announces Closing of $6.25 Million Third Tranche of Previously-Announced Convertible Notes Offering

Tue, 05/03/2016 - 13:38
ST. PAUL, Minn., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced ...
Devices, Venture Capital
EnteroMedics, neuroblocking, vBloc

Exact Sciences Completes 40,000 Cologuard Tests during First Quarter 2016

Tue, 05/03/2016 - 13:28
Revenue increases 244 percent year-over-year to $14.8 million; Commercial strategy strengthened in 2016 with television advertising campaign MADISON, Wis., May 3, 2016 -- (Healthcare Sales & Marketing Network) -- Exact Sciences Corp. (EXAS) today annou...
Diagnostics, Oncology
EXACT SCIENCES, Cologuard, colorectal cancer

Perrigo Announces FDA Approval and Launch of the Generic Version of BenzaClin(R) Pump Topical Gel

Mon, 05/02/2016 - 19:53
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced it has received final U.S. Food and Drug Administration ("FDA") approval for the generic version of Valeant Pharmaceutical In...
Biopharmaceuticals, Generics, FDA, Product Launch
Perrigo, BenzaClin, Valeant Pharmaceutical

Endo Announces U.S. District Court Ruling Upholding OPANA(R) ER Intellectual Property

Mon, 05/02/2016 - 19:49
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Endo International plc (ENDP) (ENL.TO) today announced that the U.S. District Court for the Southern District of New York has issued an order upholding its August 2015 ruling in Endo's favor...
Biopharmaceuticals, Generics, Litigation
Endo International, OPANA

EndoChoice(R) Announces William Enquist as New Chairman of the Board

Mon, 05/02/2016 - 19:45
ALPHARETTA, Ga., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- EndoChoice Holdings, Inc. (GI) announced today that existing Board member William (Bill) Enquist has been elevated to the position of Chairman of the Board of Directors. Scott Huenn...
Devices, Gastroenterology, Oncology, Personnel
EndoChoice, endoscopy, colon cancer

Graybug Vision Announces $44.5 Million Series B Financing

Mon, 05/02/2016 - 19:43
Funding Will Support Clinical Development Activities REDWOOD CITY, CA--(Healthcare Sales & Marketing Network) - Graybug Vision, a venture-stage pharmaceutical company committed to developing potentially transformative therapies for ocular diseases inclu...
Biopharmaceuticals, Ophthalmology, Venture Capital
Graybug Vision, macular degeneration

Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR(R) (rosuvastatin)

Mon, 05/02/2016 - 19:40
DUBLIN, May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Allergan plc (AGN), a leading global pharmaceutical company, today confirmed that it has received final approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug ...
Biopharmaceuticals, Generics, FDA, Product Launch
Allergan, CRESTOR, rosuvastatin, AstraZeneca

Enhanced Cystoscopy including Blue Light Cystoscopy with Cysview(R)/Hexvix(R) is Recommended in the New AUA/SUO Bladder Cancer Guideline

Mon, 05/02/2016 - 13:50
PRINCETON, N.J., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- Photocure Inc. announced today the American Urological Association (AUA) and the Society of Urological Oncology (SUO) have included enhanced cystoscopy in the 2016 Guidelines for th...
Biopharmaceuticals, Diagnostics, Urology, Oncology
Photocure, cystoscopy, bladder cancer, Cysview, Hexvix

EnteroMedics Announces Exclusive Federal Government Business Channel Sales Agreement with Academy Medical to Provide vBloc(R) Neurometabolic Therapy to US Department of Veterans Affairs Medical Facilities

Mon, 05/02/2016 - 13:39
ST. PAUL, Minn., May 2, 2016 -- (Healthcare Sales & Marketing Network) -- EnteroMedics Inc. (ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced ...
Devices, Distribution
EnteroMedics, neuroblocking, vBloc therapy

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong